Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

38.41USD
16 Aug 2019
Change (% chg)

$1.12 (+3.00%)
Prev Close
$37.29
Open
$37.54
Day's High
$38.67
Day's Low
$37.42
Volume
127,630
Avg. Vol
188,797
52-wk High
$60.98
52-wk Low
$36.19

About

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $1,444.21
Shares Outstanding(Mil.): 25.69
Dividend: --
Yield (%): --

Financials

  ESPR.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -5.77 -- --
ROI: -61.42 8.94 14.48
ROE: -61.71 10.07 15.78

Why U.S. small caps may lag despite U.S.-China trade truce

NEW YORK A truce in the trade war between the United States and China that pushed large-cap stocks to new record highs Monday does not appear to be enough to buoy the shares of small U.S. companies that are struggling under the weight of higher tariff costs.

01 Jul 2019

Why U.S. small caps may lag despite U.S.-China trade truce

NEW YORK, July 1 A truce in the trade war between the United States and China that pushed large-cap stocks to new record highs Monday does not appear to be enough to buoy the shares of small U.S. companies that are struggling under the weight of higher tariff costs.

01 Jul 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates